These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 15367659)

  • 1. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5.
    Vega RB; Harrison BC; Meadows E; Roberts CR; Papst PJ; Olson EN; McKinsey TA
    Mol Cell Biol; 2004 Oct; 24(19):8374-85. PubMed ID: 15367659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRM1 nuclear export receptor controls pathological cardiac gene expression.
    Harrison BC; Roberts CR; Hood DB; Sweeney M; Gould JM; Bush EW; McKinsey TA
    Mol Cell Biol; 2004 Dec; 24(24):10636-49. PubMed ID: 15572669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurohormonal regulation of cardiac histone deacetylase 5 nuclear localization by phosphorylation-dependent and phosphorylation-independent mechanisms.
    Haworth RS; Stathopoulou K; Candasamy AJ; Avkiran M
    Circ Res; 2012 Jun; 110(12):1585-95. PubMed ID: 22581927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of HDAC nuclear export and cardiomyocyte hypertrophy by novel irreversible inhibitors of CRM1.
    Monovich L; Koch KA; Burgis R; Osimboni E; Mann T; Wall D; Gao J; Feng Y; Vega RB; Turner BA; Hood DB; Law A; Papst PJ; Koditek D; Chapo JA; Reid BG; Melvin LS; Pagratis NC; McKinsey TA
    Biochim Biophys Acta; 2009 May; 1789(5):422-31. PubMed ID: 19414071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure.
    Bossuyt J; Helmstadter K; Wu X; Clements-Jewery H; Haworth RS; Avkiran M; Martin JL; Pogwizd SM; Bers DM
    Circ Res; 2008 Mar; 102(6):695-702. PubMed ID: 18218981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liganded peroxisome proliferator-activated receptors (PPARs) preserve nuclear histone deacetylase 5 levels in endothelin-treated Sprague-Dawley rat cardiac myocytes.
    Zhang H; Shao Z; Alibin CP; Acosta C; Anderson HD
    PLoS One; 2014; 9(12):e115258. PubMed ID: 25514029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-induced nuclear export of GFP-HDAC5 in isolated adult rat ventricular myocytes.
    Peng Y; Lambert AA; Papst P; Pitts KR
    J Pharmacol Toxicol Methods; 2009; 59(3):135-40. PubMed ID: 19328241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy.
    Ha CH; Kim JY; Zhao J; Wang W; Jhun BS; Wong C; Jin ZG
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15467-72. PubMed ID: 20716686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
    Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
    Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear calcium/calmodulin-dependent protein kinase IIdelta preferentially transmits signals to histone deacetylase 4 in cardiac cells.
    Little GH; Bai Y; Williams T; Poizat C
    J Biol Chem; 2007 Mar; 282(10):7219-31. PubMed ID: 17179159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5.
    He T; Huang J; Chen L; Han G; Stanmore D; Krebs-Haupenthal J; Avkiran M; Hagenmüller M; Backs J
    J Mol Cell Cardiol; 2020 Aug; 145():88-98. PubMed ID: 32485181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional regulation of HDAC5 by mAKAPβ signalosomes in cardiac myocytes.
    Dodge-Kafka KL; Gildart M; Li J; Thakur H; Kapiloff MS
    J Mol Cell Cardiol; 2018 May; 118():13-25. PubMed ID: 29522762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
    Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel kinase inhibitor establishes a predominant role for protein kinase D as a cardiac class IIa histone deacetylase kinase.
    Monovich L; Vega RB; Meredith E; Miranda K; Rao C; Capparelli M; Lemon DD; Phan D; Koch KA; Chapo JA; Hood DB; McKinsey TA
    FEBS Lett; 2010 Feb; 584(3):631-7. PubMed ID: 20018189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.
    Ferguson BS; Harrison BC; Jeong MY; Reid BG; Wempe MF; Wagner FF; Holson EB; McKinsey TA
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9806-11. PubMed ID: 23720316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute β-adrenergic activation triggers nuclear import of histone deacetylase 5 and delays G(q)-induced transcriptional activation.
    Chang CW; Lee L; Yu D; Dao K; Bossuyt J; Bers DM
    J Biol Chem; 2013 Jan; 288(1):192-204. PubMed ID: 23161540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatiotemporally distinct protein kinase D activation in adult cardiomyocytes in response to phenylephrine and endothelin.
    Bossuyt J; Chang CW; Helmstadter K; Kunkel MT; Newton AC; Campbell KS; Martin JL; Bossuyt S; Robia SL; Bers DM
    J Biol Chem; 2011 Sep; 286(38):33390-400. PubMed ID: 21795686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5) Nuclear Accumulation in Cardiomyocytes by B55α-PP2A-Mediated Dephosphorylation.
    Weeks KL; Ranieri A; Karaś A; Bernardo BC; Ashcroft AS; Molenaar C; McMullen JR; Avkiran M
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28343149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.
    Carnegie GK; Soughayer J; Smith FD; Pedroja BS; Zhang F; Diviani D; Bristow MR; Kunkel MT; Newton AC; Langeberg LK; Scott JD
    Mol Cell; 2008 Oct; 32(2):169-79. PubMed ID: 18951085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YY1 protects cardiac myocytes from pathologic hypertrophy by interacting with HDAC5.
    Sucharov CC; Dockstader K; McKinsey TA
    Mol Biol Cell; 2008 Oct; 19(10):4141-53. PubMed ID: 18632988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.